Table 7.6b

Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006

Recipients with Pancreas After Kidney (PAK) Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac CyA+ MMF Tac+ MMF CyA+ Aza Tac+ Aza Siro+ MMF CyA+ Siro Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 6 68 82 1,050 1 6 23 29 146 157 1,568
% of All Regimens 0.4% 4.3% 5.2% 67.0% 0.1% 0.4% 1.5% 1.8% 9.3% 10.0% 100.0%
Induction Drug 0.0% 0.0% 0.0% 2.2% 0.0% 0.0% 4.3% 0.0% 1.4% 1.3% 1.8%
Atgam/NRATG/NRATS
OKT3 0.0% 0.0% 0.0% 0.5% 0.0% 0.0% 0.0% 0.0% 1.4% 2.5% 0.7%
Thymoglobulin 66.7% 16.2% 61.0% 55.5% 0.0% 50.0% 56.5% 89.7% 52.1% 108.9% 59.8%
Zenapax 0.0% 4.4% 14.6% 10.6% 0.0% 0.0% 0.0% 0.0% 17.8% 19.7% 11.7%
Simulect 0.0% 1.5% 15.9% 6.8% 0.0% 0.0% 4.3% 10.3% 3.4% 8.9% 6.9%
Campath 16.7% 30.9% 11.0% 7.3% 0.0% 33.3% 21.7% 0.0% 16.4% 53.5% 14.2%
No Induction Drugs Recorded 33.3% 48.5% 12.2% 22.9% 100.0% 16.7% 30.4% 3.4% 24.7% 12.1% 22.3%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.